Many therapies regulating tumor pH utilize small compounds or nanoparticles to suppress pH regulators like CA9, NHE1, among others, amplifying the effectiveness of various treatments including chemotherapy [2], radiotherapy [10], photodynamic therapy (PDT) [20], and chemodynamic therapy (CDT) [21, 22]. Here, SLC9A1 is linked to neoplasm.